Endocrine-Disrupting Chemicals and Female Reproductive Aging
Seminars in Reproductive Medicine · 2024-12 · 42 (04) · 330-360
DOI: 10.1055/s-0044-1801388 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Reproductive Medicine, online erschienen am 29.01.2025. Verfasst von Jiaxin Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan. Hauptthemen laut MEDLINE: Endocrine Disruptors, Aging, Reproduction, Ovary. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 122 Literaturangaben. Gefördert von: NIEHS NIH HHS.
Abstract (Originalsprache)
Female reproductive aging often affects women's emotional, physical, and physiological well-being. Ovarian aging is characterized by fluctuations in reproductive hormones and determines the age at which menopause occurs. Understanding potentially modifiable factors that influence this process is essential for addressing health disparities, improving quality of life, and informing relevant public health strategies. This review synthesizes in vivo, in vitro, and epidemiological findings about the effects of endocrine-disrupting chemicals (EDCs), specifically heavy metals and perfluoroalkyl and polyfluoroalkyl substances (PFAS) on female reproductive aging. Most in vivo and in vitro studies have demonstrated that heavy metals alter ovarian morphology, folliculogenesis, and steroidogenesis. Evidence regarding the effects of PFAS is limited and inconsistent. Epidemiological studies have consistently shown that heavy metals are associated with a higher risk of diminished ovarian reserve (indicated by decreased anti-Müllerian hormone) and earlier menopause, with limited findings regarding reproductive hormone changes. PFAS exposure has been associated with decreased estradiol and earlier menopause but not significantly with ovarian reserve. Gaps in the literature require more comprehensive epidemiological research on the effects of EDCs on female reproductive aging, including ovarian reserve, age at menopause, and vasomotor symptoms, to inform future interventions to reduce hazardous exposures and improve women's health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan.
- Department of Obstetrics and Gynecology, School of Medicine, University of Michigan, Ann Arbor, Michigan.
- Department of Public Health Sciences, University of California Davis School of Medicine, Davis, California.
- Department of Environmental Health Sciences, School of Public Health, University of Michigan, Ann Arbor, Michigan.
Förderung
- NIEHS NIH HHS
Zitieren
APA
Wu, J., Harlow, S. D., Randolph, J. F., Gold, E. B., & Park, S. K. (2024). Endocrine-Disrupting Chemicals and Female Reproductive Aging. Seminars in Reproductive Medicine, 42(04), 330-360. https://doi.org/10.1055/s-0044-1801388
Vancouver
Wu J, Harlow SD, Randolph JF, Gold EB, Park SK. Endocrine-Disrupting Chemicals and Female Reproductive Aging. Seminars in Reproductive Medicine. 2024;42(04):330-360. doi:10.1055/s-0044-1801388
BibTeX
@article{Wu2024,
author = {Wu, Jiaxin and Harlow, Siobán D and Randolph, John F and Gold, Ellen B and Park, Sung Kyun},
title = {Endocrine-Disrupting Chemicals and Female Reproductive Aging},
journal = {Seminars in Reproductive Medicine},
year = {2024},
volume = {42},
number = {04},
pages = {330--360},
doi = {10.1055/s-0044-1801388}
}
EUVIMED